TY - CHAP
T1 - Tau Accumulation and Network Breakdown in Alzheimer’s Disease
AU - Watanabe, Hirohisa
AU - Bagarinao, Epifanio
AU - Yokoi, Takamasa
AU - Yamaguchi, Hiroshi
AU - Ishigaki, Shinsuke
AU - Mausuda, Michihito
AU - Katsuno, Masahisa
AU - Sobue, Gen
N1 - Publisher Copyright:
© Springer Nature Singapore Pte Ltd. 2019.
PY - 2019
Y1 - 2019
N2 - Misfolded and aggregated tau and amyloid β (Aβ) proteins are the pathological hallmarks of Alzheimer’s disease (AD). These aberrant proteins lose their physiological roles, acquire neurotoxicity, and propagate across neural systems. Despite the growing understanding of the molecular pathophysiology, the relationship among molecular alterations, pathological changes, and dementia onset and progression remain to be elucidated. Connectivity is an exclusive characteristic of the brain, and the integrity and segregation of the functional and anatomical networks are crucial for normal functioning. Interestingly, a lot of magnetic resonance imaging (MRI) studies have demonstrated successive structural and functional disconnection among brain regions supporting the idea that AD is a disconnection syndrome. Recent several studies using the combination of cutting-edge Aβ and tau PET tracers integrated by data-driven statistical methods, resting-state functional MRI, and diffusion tensor imaging have shed light on the spatial distribution pattern of tau retention as well the relationship between tau retention and functional/structural network disruption in AD. Regional retention of tau PET traces is associated with gray matter changes, structural network disruption, and cognitive function tests. The tau retention will mainly spread along with cognition-related resting state networks and be more common in the network hubs which exhibit many strong interconnections with other regions within the network as well as without the networks. Mainly, precuneus and posterior cingulate gyrus are commonly involved and can be the critical nodes associated with clinically manifested dementia from the normal cognitive state.
AB - Misfolded and aggregated tau and amyloid β (Aβ) proteins are the pathological hallmarks of Alzheimer’s disease (AD). These aberrant proteins lose their physiological roles, acquire neurotoxicity, and propagate across neural systems. Despite the growing understanding of the molecular pathophysiology, the relationship among molecular alterations, pathological changes, and dementia onset and progression remain to be elucidated. Connectivity is an exclusive characteristic of the brain, and the integrity and segregation of the functional and anatomical networks are crucial for normal functioning. Interestingly, a lot of magnetic resonance imaging (MRI) studies have demonstrated successive structural and functional disconnection among brain regions supporting the idea that AD is a disconnection syndrome. Recent several studies using the combination of cutting-edge Aβ and tau PET tracers integrated by data-driven statistical methods, resting-state functional MRI, and diffusion tensor imaging have shed light on the spatial distribution pattern of tau retention as well the relationship between tau retention and functional/structural network disruption in AD. Regional retention of tau PET traces is associated with gray matter changes, structural network disruption, and cognitive function tests. The tau retention will mainly spread along with cognition-related resting state networks and be more common in the network hubs which exhibit many strong interconnections with other regions within the network as well as without the networks. Mainly, precuneus and posterior cingulate gyrus are commonly involved and can be the critical nodes associated with clinically manifested dementia from the normal cognitive state.
UR - http://www.scopus.com/inward/record.url?scp=85080878233&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85080878233&partnerID=8YFLogxK
U2 - 10.1007/978-981-32-9358-8_19
DO - 10.1007/978-981-32-9358-8_19
M3 - Chapter
C2 - 32096042
AN - SCOPUS:85080878233
T3 - Advances in Experimental Medicine and Biology
SP - 231
EP - 240
BT - Advances in Experimental Medicine and Biology
PB - Springer
ER -